ライフサイエンスコーパス: nondepressed

1 fluence hippocampal size (n = 8 depressed, 8 nondepressed).

2 ded in the primary analysis (depressed, 559; nondepressed, 308).

3 t of substance use disorder in depressed and nondepressed adolescents, and whether substance use diso

4 Two primary care physicians (PCPs) and 5236 nondepressed adult patients were randomly sampled from e

5 d controls (n = 11) and in a larger group of nondepressed adults who were > or = 60 years old.

6 Use of desipramine to reduce relapse in nondepressed alcoholics is not supported.

7 In most cases, transitions between the nondepressed and depressed states were characterized by

8 The 3 outcome states were depressed, nondepressed, and death, with scores of 20 or more and l

9 nts who were depressed and in those who were nondepressed at enrollment, after the effects of other f

10 ups, with mean scores in the range of normal/nondepressed by the end of the study.

11 Nondepressed children with recently diagnosed OCD who ha

12 upport on hippocampal volumes was greater in nondepressed children.

13 linically mixed and nonmixed patients in the nondepressed cluster revealed that the mixed patients in

14 essed cluster, and about 40% of those in the nondepressed cluster, were in a mixed state according to

15 ervention patients did not reach that of the nondepressed comparison group.

16 Nondepressed comparison subjects (N=17) and depressed in

17 depressed patients 59 to 78 years old and 47 nondepressed comparison subjects 55 to 81 years old.

18 cipants currently taking antidepressants and nondepressed comparison subjects demonstrated greater to

19 irty-three elderly depressed patients and 27 nondepressed comparison subjects participated in this st

20 ed to both nonsuicidal depressed elderly and nondepressed comparison subjects, after controlling for

21 the subjects with primary depression and the nondepressed comparison subjects, but the Alzheimer's di

22 31 (31P) MRS were acquired for depressed and nondepressed comparison subjects.

23 depression in remission and 16 case-matched nondepressed comparison subjects.

24 g scans of 24 depressed women and 24 matched nondepressed comparison subjects.

25 ndividuals with major depression relative to nondepressed comparison subjects.

26 th major depressive disorder and age-matched nondepressed comparison subjects.

27 ed in the depressed patients relative to the nondepressed comparison subjects.

28 ideators, nonsuicidal depressed elderly, and nondepressed comparison subjects.

29 bjects with primary major depression and the nondepressed comparison subjects.

30 y either screening or clinical criteria) and nondepressed control subjects.

31 ion (n = 11) to that in age- and sex-matched nondepressed controls (n = 11) and in a larger group of

32 ts with co-occurring anxiety and 33 matched, nondepressed controls at baseline and after 12 weeks (of

33 edicated outpatients with MDD and 20 matched nondepressed controls completed rs-fcMRI scans after whi

34 lowing administration of zoster vaccine than nondepressed controls or depressed subjects receiving an

35 are them with similar measures obtained from nondepressed controls.

36 sed with late-onset major depression, and 30 nondepressed controls.

37 impairment in executive functions than their nondepressed counterparts.

38 otic symptoms and behavioral disturbances in nondepressed, demented patients.

39 s (namely, from nondepressed or depressed to nondepressed, depressed, or death) was evaluated over ti

40 ) and without (N=7) comorbid depression, and nondepressed elderly comparison subjects (N=10).

41 onbipolar major depression (unmedicated) and nondepressed elderly comparison subjects.

42 uantify the presence of CRN in depressed and nondepressed elderly Medicare beneficiaries and nonelder

43 47% to 51% higher in depressed compared with nondepressed elderly patients after adjustment for chron

44 in depressed elderly subjects with those of nondepressed elderly subjects by using voxel-based morph

45 in depressed elderly subjects, compared with nondepressed elderly subjects, and in Alzheimer's diseas

46 articipants (135,007 depressed and 1,678,726 nondepressed) from 35 countries were included.

47 t side in the depressed subjects than in the nondepressed group.

48 tion of WMH by fMRI activity effect than the nondepressed group.

49 quality of life at 1 year compared with the nondepressed group.

50 nd assigned to either a depressed group or a nondepressed group.

51 ovascular costs $1,550 to $3,300 higher than nondepressed groups (r = 0.08 to 0.12, p < 0.05).

52 per 1,000 person-years for the depressed and nondepressed groups, respectively.

53 ignificantly different between depressed and nondepressed groups.

54 re untreated during pregnancy (N=54), and 4) nondepressed, healthy women (N=62).

55 pressed high utilizers were more likely than nondepressed high utilizers to have higher medical costs

56 01), although expenditures for depressed and nondepressed high utilizers were similar for the previou

57 the amygdala, insula, and thalamus, whereas nondepressed individuals exhibit the opposite pattern.

58 ing an effortful affective reappraisal task, nondepressed individuals showed an inverse relationship

59 (PFC) when downregulating negative affect in nondepressed individuals, whereas depressed individuals

60 Fifty-eight nondepressed inpatients with schizophrenia, 25 nonpsycho

61 fspring of depressed (high familial risk) or nondepressed (low familiar risk) probands (first generat

62 n age=47 years) of depressed (high-risk) and nondepressed (low-risk) parents.

63 nd increased early life stress (N=14) versus nondepressed male comparison subjects (N=14) before and

64 lon4 nor depression, the risk of dementia in nondepressed men with APOE epsilon4 was not significant

65 erior hippocampus of depressed compared with nondepressed monkeys.

66 ificantly lower than that of the children of nondepressed mothers (112).

67 febrile illness in children of depressed and nondepressed mothers was estimated using a recurrent eve

68 d mothers compared with those in children of nondepressed mothers were 1.57 (95% confidence interval:

69 f depressed mothers (compared to partners of nondepressed mothers) and to examine how these paternal

70 Depressed and nondepressed mothers, their partners (the biological fat

71 sorder, compared with 15% of the children of nondepressed mothers.

72 t problematic behaviors than the children of nondepressed mothers.

73 00 person-years among those depressed versus nondepressed, multiadjusted hazard ratios [95% confidenc

74 e death did not differ between depressed and nondepressed newly bereaved subjects.

75 SSRI) antidepressants, and infants born to a nondepressed, nonmedicated comparison group across the f

76 ed with a decrease in striatal metabolism in nondepressed OCD patients but with an increase in striat

77 ikelihood of transitioning from depressed to nondepressed (odds ratio, 0.27; 95% confidence interval,

78 hood of 6 possible transitions (namely, from nondepressed or depressed to nondepressed, depressed, or

79 One hundred seventy-six nondepressed outpatients with panic disorder, with or wi

80 en (generation 3) of depressed compared with nondepressed parents (generation 2) had 2-fold increased

81 pring of moderately to severely depressed or nondepressed parents selected from the same community we

82 year follow-up of offspring of depressed and nondepressed parents to determine the magnitude and cont

83 ts were 114 adult offspring of depressed and nondepressed parents, followed longitudinally.

84 ffspring of depressed parents, compared with nondepressed parents, had more serious and impairing dep

85 of depressed parents as in the offspring of nondepressed parents.

86 depressed parent as compared with those with nondepressed parents.

87 ortality was reported for both depressed and nondepressed participants at follow-up.

88 METHOD: Data sets from 755 currently nondepressed participants from the longitudinal Alzheime

89 e risk of mortality in depressed relative to nondepressed participants was 1.64 (95% CI=1.56-1.76), w

90 scores on all cognitive composites than the nondepressed participants.

91 have a three-fold greater risk of dying than nondepressed patients (95% CI, 1.07 to 8.30; P =.04) bet

92 mmendations for an antidepressant drug among nondepressed patients could not be excluded.

93 s in speech production between depressed and nondepressed patients have been suggested as a potential

94 The nondepressed patients showed essentially no change in co

95 depression were nine times more likely than nondepressed patients to drop out of prolonged exposure

96 robability of survival for the depressed and nondepressed patients was 85% (95% confidence interval [

97 trial for prevention of depression among 176 nondepressed patients was conducted within 3 months foll

98 Both depressed and nondepressed patients were enrolled to determine whether

99 Studies with data contrasting depressed vs nondepressed patients who did and did not later develop

100 on after onset of Alzheimer's disease and 74 nondepressed patients with Alzheimer's disease.

101 ssed patients' cognitive status with that of nondepressed patients with comparable lesions.

102 of psychosis and behavioral disturbances in nondepressed patients with dementia.

103 istered to 18 psychotropic medication-naive, nondepressed patients with OCD aged 8.8 to 16.9 years an

104 In this study of nondepressed patients with recent stroke, the use of esc

105 Rates of relapse of depressed vs nondepressed patients, analyzed separately, were not sig

106 ospital and outpatient medical services than nondepressed patients, but they did not receive more men

107 Among nondepressed patients, clinician-reported antidepressant

108 Among nondepressed patients, noninferiority assessment of clin

109 ed medical utilization between depressed and nondepressed patients, we conducted a study that focused

110 ive or social functioning among depressed or nondepressed patients.

111 medical visits in the past 3 months than did nondepressed patients.

112 ction were 3.5 times more likely to die than nondepressed patients.

113 its were no more common among depressed than nondepressed patients.

114 confidence interval 1.10-1.67) compared with nondepressed patients.

115 ers, and to abuse alcohol or drugs than were nondepressed patients.

116 increased the survival of both depressed and nondepressed patients.

117 s, the rates were 54.1 (depressed) and 41.5 (nondepressed) per 1,000 person-years.

118 al women attending a menopause clinic and 35 nondepressed perimenopausal women.

119 Social anxiety disorder in nondepressed persons at baseline was associated with an

120 Nondepressed pregnant women with at least one past episo

121 dies Depression Scale denoting depressed and nondepressed, respectively.

122 oking after hospital discharge compared with nondepressed smokers.

123 -blind treatment study were compared with 42 nondepressed stroke patients who remained nondepressed t

124 sed several depression stigma attitudes than nondepressed students.

125 ) deficiency was present in 14.9% of the 478 nondepressed subjects, 17.0% of the 100 mildly depressed

126 Compared to the nondepressed subjects, the patients had significantly lo

127 ubjects and a matched comparison group of 20 nondepressed subjects.

128 tly lower serum vitamin B(12) level than the nondepressed subjects.

129 obtained on the same day from depressed and nondepressed subjects.

130 were assessed in comparison with 21 matched nondepressed subjects.

131 od zinc concentrations between depressed and nondepressed subjects.

132 ike broadening and synaptic facilitation for nondepressed synapses is the inverse of that in adults.

133 However, in nondepressed synapses, 5-HT-induced facilitation is not

134 pendent (SDD) facilitation], particularly at nondepressed synapses.

135 masked, and SDD facilitation predominates at nondepressed synapses.

136 42 nondepressed stroke patients who remained nondepressed throughout the follow-up.

137 ad a higher likelihood of transitioning from nondepressed to depressed (odds ratio, 2.02; 95% confide

138 th major depression compared with a group of nondepressed volunteer subjects.

139 Clinical Interview for DSM-III-R and from 10 nondepressed volunteers (seven were women).

140 rocessing of positively valenced material in nondepressed volunteers.

141 -up were classified into depressed (n = 44), nondepressed with other neuropsychiatric symptoms (n = 9

142 Nondepressed with other neuropsychiatric symptoms and NO

143 ss-sectional sample of 318 depressed and 658 nondepressed women between the ages of 36 and 44 who wer

144 Finally, 21% of the depressed and 3% of the nondepressed women met criteria for premenstrual dysphor

145 -one percent of the depressed and 20% of the nondepressed women met criteria for significant menses-r

146 y-six percent of the depressed and 9% of the nondepressed women reported premenstrual symptoms.

147 d premenopausal women with depression and 25 nondepressed women who were matched by age and menstrual

148 dvantage for processing words, compared with nondepressed women, but this difference was not seen amo

149 Compared with nondepressed women, depressed women with more pronounced

150 y compared striatal volumes in depressed and nondepressed women, screened to exclude major cerebrovas

151 o, 2.7; 95% confidence interval, 1.5-4.8) of nondepressed women.